Synapticure, a virtual care provider for seniors with neurodegenerative conditions, and the Amyotrophic Lateral Sclerosis (ALS) Association have partnered to improve access and quality of care for ALS patients across the US.
Through the partnership, Synapticure's telemedicine platform would be made available to members of the ALS Association to supplement in-person visits at certified ALS treatment centers, primarily benefiting those living in remote areas. With Synapticure's asynchronous model offering flexibility in scheduling and monitoring, the partnership further alleviates the burden on ALS patients and their caregivers. Additionally, ALS patients will get access to local and national resources, with a designated ALS Association liaison offering customized support within Synapticure's virtual clinic.
Synapticure is a telehealth provider that offers personalized care for individuals living with neurodegenerative diseases such as ALS, Alzheimer’s, and Parkinson’s disease. Synapticure's services include personalized care plans developed through advanced testing, data analytics, and consultations with neurodegenerative disease specialists. The company’s specialized platform provides caregiver education and support, identifies potential clinical trials to enroll patients in, and assigns a dedicated nurse or social worker for care coordination.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.